Concepedia

Increased Potency of a Novel Complement Factor 5a Receptor Antagonist in a Rat Model of Inflammatory Bowel Disease

Trent M. Woodruff, Sandra Pollitt, Lavinia M. Proctor, Shelli Z Stocks, Helga D. Manthey, Hua M. Williams, I. B. Mahadevan, Ian A. Shiels, Stephen M. Taylor

Journal of Pharmacology and Experimental Therapeutics · 2005 · 82 citations · 25 references

DOI

Concepts

References

25

Antibodies to interleukin 12 abrogate established experimental colitis in mice.

MF Neurath, Ivan J. Fuss, Brian L. Kelsall et al. · The Journal of Experimental Medicine · 1995 · 1.3K citations · Full text

, , +17

Inflammatory mediators of experimental colitis in rats

D Rachmilewitz, P L Simon, Lester W. Schwartz et al. · Gastroenterology · 1989 · 256 citations

, , +14

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

Catalina Abad, Carmen Martínez, Marı́a G. Juarranz et al. · Gastroenterology · 2003 · 255 citations · Full text

, , +16

A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats

Thiruma V. Arumugam, Ian A. Shiels, Anna J. Strachan et al. · Kidney International · 2003 · 205 citations · Full text

, , +11

Epithelial Deposition of Immunoglobulin G1 and Activated Complement (C3b and Terminal Complement Complex) in Ulcerative Colitis

Trond S. Halstensen, Tom Eirik Mollnes, Peter Garred et al. · Gastroenterology · 1990 · 145 citations

, , +17